NASDAQ:OFIX - Orthofix Medical Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $39.00
  • Forecasted Upside: 1.99 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$38.24
▼ -0.14 (-0.36%)

This chart shows the closing price for OFIX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Orthofix Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OFIX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OFIX

Analyst Price Target is $39.00
▲ +1.99% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Orthofix Medical in the last 3 months. The average price target is $39.00, with a high forecast of $39.00 and a low forecast of $39.00. The average price target represents a 1.99% upside from the last price of $38.24.

This chart shows the closing price for OFIX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 1 investment analysts is to hold stock in Orthofix Medical. This rating has held steady since October 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/4/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/4/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/2/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/31/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/28/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/28/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/20/2020Stifel NicolausInitiated CoverageHold$39.00Medium
2/25/2020SidotiLower Price TargetBuy$70.00 ➝ $56.00High
2/25/2020Cantor FitzgeraldLower Price TargetNeutral$48.00 ➝ $42.00High
10/29/2019Cantor FitzgeraldDowngradeOverweight ➝ Neutral$71.00 ➝ $48.00Low
2/26/2019BTIG ResearchReiterated RatingBuy ➝ NeutralHigh
1/18/2019Cantor FitzgeraldSet Price TargetBuy$60.00Low
1/8/2019Cantor FitzgeraldSet Price TargetBuy$66.00Low
8/7/2018Cantor FitzgeraldBoost Price TargetOverweight$66.00High
5/31/2018Cantor FitzgeraldInitiated CoverageOverweight$62.00Medium
3/5/2018SunTrust BanksBoost Price TargetBuy$67.00High
2/28/2018GabelliReiterated RatingBuyLow
10/30/2017BTIG ResearchSet Price TargetBuy$56.00N/A
8/10/2017Jefferies Financial GroupReiterated RatingBuy$50.00 ➝ $55.00Low
6/21/2017BTIG ResearchInitiated CoverageBuy$52.00High
6/14/2017Langenberg & CompanyReiterated RatingBuy$53.25Low
6/14/2017LADENBURG THALM/SH SHInitiated CoverageBuy ➝ Buy$53.25Low
5/23/2017SunTrust BanksInitiated CoverageBuy ➝ Buy$49.00Medium
(Data available from 7/28/2016 forward)
Orthofix Medical logo
Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Extremities. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The Global Extremities segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.
Read More

Today's Range

Now: $38.24
Low: $37.92
High: $39.31

50 Day Range

MA: $40.32
Low: $37.34
High: $42.48

52 Week Range

Now: $38.24
Low: $28.03
High: $48.50

Volume

40,126 shs

Average Volume

85,630 shs

Market Capitalization

$747.94 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.14

Frequently Asked Questions

What sell-side analysts currently cover shares of Orthofix Medical?

The following equities research analysts have issued research reports on Orthofix Medical in the last twelve months: Stifel Nicolaus, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for OFIX.

What is the current price target for Orthofix Medical?

1 Wall Street analysts have set twelve-month price targets for Orthofix Medical in the last year. Their average twelve-month price target is $39.00, suggesting a possible upside of 2.0%. Stifel Nicolaus has the highest price target set, predicting OFIX will reach $39.00 in the next twelve months. Stifel Nicolaus has the lowest price target set, forecasting a price of $39.00 for Orthofix Medical in the next year.
View the latest price targets for OFIX.

What is the current consensus analyst rating for Orthofix Medical?

Orthofix Medical currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in OFIX, but not buy more shares or sell existing shares.
View the latest ratings for OFIX.

What other companies compete with Orthofix Medical?

How do I contact Orthofix Medical's investor relations team?

Orthofix Medical's physical mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company's listed phone number is 214-937-2000 and its investor relations email address is [email protected] The official website for Orthofix Medical is www.orthofix.com.